Horizon Therapeutics PLC (NASDAQ:HZNP)

23.28
Delayed Data
As of Jun 24
 -0.49 / -2.06%
Today’s Change
15.92
Today|||52-Week Range
29.44
+19.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues757.0M1.0B1.1B1.2B
 
 
 
 
 
Cost of Goods Sold60.0M173.9M262.9M146.6M
 
 
 
 
 
Depreciation And Amortization138.3M221.8M283.4M275.7M
 
 
 
 
 
 
Operating ExpensesGross Income558.7M650.4M510.0M785.3M
 
 
 
 
 
General Expenses436.6M651.5M902.3M769.5M
 
 
 
 
 
Research And Development38.8M60.2M225.0M82.8M
 
 
 
 
 
Total Operating Expenses634.9M1.0B1.4B1.2B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income122.2M-1.1M-392.4M15.8M
 
 
 
 
 
Extraordinary Credit0.002.5M0.000.00
 
 
Extraordinary Charge-154.4M-148.6M-978.0K-56.1M
 
 
 
 
 
Interest Expense On Debt69.9M86.6M126.5M121.7M
 
 
 
 
 
Other Expenses-30.6M5.7M6.6M42.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-132.7M-228.1M-513.3M-119.1M
 
 
 
 
 
Income Taxes-172.2M-61.3M-102.7M-45.0M
 
 
 
 
 
Net Income39.5M-166.8M-410.5M-74.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS148.8M160.7M163.1M166.2M
 
 
 
 
 
Shares To Calculate EPS Diluted155.9M160.7M163.1M166.2M
 
 
 
 
 
 
Earnings Per ShareEPS$0.25-$1.04-$2.52-$0.45
 
 
 
 
 
EPS Diluted$0.25-$1.04-$2.52-$0.45